Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-16

Clinical Trial Update: A Dose-Image Optimization Trial Evaluating Mannitol and Voluven as Adjuncts for Indocyanine Green [Phase 1, Phase 2]

View source ↗

Summary

This phase 1/2 clinical trial from National Taiwan University Hospital evaluates Mannitol and Voluven as adjuncts to Indocyanine Green for dose-image optimizati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mannitol (mannitol)
  • Voluven (hydroxyethyl starch 130/0.4)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION